Ishikawa, Nobuhisa
-
Vol 12, No 3 (March 23, 2020): Journal of Thoracic Disease - Study Protocol
Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer
Abstract PDF Full Text